We serve Chemical Name:5-bromo-2-indolecarboxylic acid CAS:7254-19-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-bromo-2-indolecarboxylic acid
CAS.NO:7254-19-5
Synonyms:5-Bromo-1H-indole-2-carboxylic acid;5-bromo-2-indolecarboxylic acid;MFCD00022705;1H-Indole-2-carboxylic acid, 5-bromo-;5-Bromoindole-2-carboxylic acid
Molecular Formula:C9H6BrNO2
Molecular Weight:240.053
HS Code:29339980
Physical and Chemical Properties:
Melting point:287-288ºC
Boiling point:470.9±25.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.749
PSA:53.09000
Exact Mass:238.958176
LogP:3.17
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 5-Bromo-1H-indole-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Bromoindole-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Bromo-1H-indole-2-carboxylic acid Use and application,5-bromo-2-indolecarboxylic acid technical grade,usp/ep/jp grade.
Related News: Biogen’s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug. barium(2+),hexacosanoate manufacturers EMA said it considered that the results of the clinical studies used to support the application “were inconsistent and did not satisfactorily show that Nouryant was effective at reducing the ‘off’ time. N-amino mesitylenesulfonate salt of isoquinoline suppliers The suit says that while BRAF kinase inhibitors existed prior to Plexxikon’s discoveries, they were not selective, and Plexxikon’s have a core molecular structure that allows them to bind selectively to kinase created by the BRAF mutation. That allows for higher doses to be administered. Manganese, chloro[4-(dimethylamino)phenyl]- vendor & factory The suit says that while BRAF kinase inhibitors existed prior to Plexxikon’s discoveries, they were not selective, and Plexxikon’s have a core molecular structure that allows them to bind selectively to kinase created by the BRAF mutation. That allows for higher doses to be administered.,The incredible selectivity of enzyme catalysts consequently simplifies workflows by generating fewer by-products and reducing impurities to markedly decrease the total number of synthetic steps required.
